The late Steve Jobs of Apple said “I think the biggest innovation of the 21st century will be at the intersection of biology and technology, a new era is beginning”.
If you want to see how biotech can change the world of health, whilst potentially being capable of creating extraordinary value for investors, there are few better places to look than Amgen, one of the world’s leading independent biotech companies. With a market capitalization of approximately $130bn, Amgen has been an extraordinary success story.
In this conversation, Bob discusses the big areas of medical need, from cardiovascular problems which continue to make it the world’s greatest killer, through to genetics, obesity, osteoporosis and cancers.
Bob discusses timelines and priorities, the use of A.I. in accelerating drug development, biologics, facing setbacks on the road to approvals, and the challenge of running a company which has a presence in over 100 countries.
TOPICS:
00:00 - Intro & Guest Background
03:03 - Bradway's Time at Morgan Stanley
04:40 - Amgen Background & Evolution
07:08 - The Difference Between Biotech & Pharmaceuticals
07:45 - 10 Year Mission
08:16 - Drug Development & Approval
09:51 - Amgen's Approach to Cardiovascular Disease
11:05 - Human Genetics
14:15 - Risk & Reward of Medicine Development
16:49 - Biologics
19:17 - Obesity & Biology
21:12 - Micromet & Cancer
23:18 - AI & Drug Development
26:22 - Challenges of Running a Large Corporation
28:10 - Handling Setbacks
30:14 - Closing Questions
35:07 - Outro
Subscribe to stay up to date with our range of fascinating interviews, featuring some of the biggest names in global finance and business!
SPONSORS:
- Schroders is a global investment and wealth manager, with a purpose to provide excellent investment performance to clients, through active investment management. Find out more: [ Ссылка ]
- Bremont is an award winning British company that produces beautifully engineered chronometers, designed to appeal to those who share the passion and appreciation of the innovation and mastery behind a beautiful mechanical wristwatch. Find out more: [ Ссылка ]
- LiveTrade, from Bordeaux Index, is an innovative new platform which allows you to instantly buy and sell - or place bids and offers on - key wines from around the world. Find out more: [ Ссылка ]
- Mintus allows you to 'own to unownable' via its FCA authorised and regulated fractionalised art investment platform. Find out more: [ Ссылка ]
DISCLAIMER
All content on the Money Maze Podcast is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions. Guests and presenters may have positions in any of the investments discussed.
